Skip to main content
Log in

Phased RF ablation with PVAC gold: evolution favors only the strong

  • Commentary
  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. John Hummel MD, Gregory Michaud MD, FHRS, Robert Hoyt MD, et al. Phased RF ablation in persistent atrial fibrillation. Heart Rhythm. 2014;11:202–9.

    Article  PubMed  Google Scholar 

  2. De Greef Y, Dekker L, Boersma L, et al. Low rate of asymptomatic cerebral embolism and improved procedural efficiency with the novel pulmonary vein ablation catheter GOLD: results of the PRECISION GOLD Trial. Europace. 2016;18(5):687–95.

    Article  PubMed  PubMed Central  Google Scholar 

  3. John Hummel MD, Atul Verma MD, Hugh Calkins MD, et al. Evaluation of stroke incidence with duty-cycled mutielectrode-phased radiofrequency ablation of persistent atrial fibrillation results of the VICTORY AF study. J Cardiovasc Electrophysiol. 2020;31:1289–97.

    Article  PubMed  Google Scholar 

  4. Klaver MN, Wintgens LIS, Wijffels MCEF, et al. 2-year outcomes of phased radiofrequency ablation for atrial fibrillation with the second-generation PVAC Gold ablation catheter. J Interv Card Electrophysiol. 2022. https://doi.org/10.1007/s10840-022-01249-2

  5. Klaver MN, Wintgens LIS, Wijffels MCEF, et al. Acute success and safety of the second-generation PVAC GOLD phased RF ablation catheter for atrial fibrillation. J Interv Cardiac Electrophysiol 2020. https://doi.org/10.1007/s108-020-00728-8

  6. Essebag V, Azizi Z, Alipour P, et al. Comparison of efficacy of phased multipolar versus traditional radiofrequency ablation: a prospective muticenter study (CAPCOST). Pacing Clin Electrophysiol 2019. https://doi.org/10.1111/pace.13737

  7. Kuch K-H, Brugada J, Furnkranz A, et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. NEJM. 2016;374:2235–45.

    Article  Google Scholar 

  8. Seidl P, Steinborn F, Costello-Boerrigter L, et al. Pulmonary vein isolation using second-generation single-shot devices: not all the same? J Interv Cardiac Electrohysiol 2020. https://doi.org/10.1007/s10840-020-00751-9

  9. Mansour M, Calkins H, Osorio J, et al. Persistent atrial fibrillation ablation with force-sensing catheter. JACC EP. 2020;6(8):958–69.

    Google Scholar 

  10. Wintgens LIS, Klaver M, Maarse M, et al. Efficacy and safety of the GOLD FORCE multicentre randomized clinical trial: multielectrode phased radiofrequency vs. irrigated radiofrequency single-tip catheter with force ablation for treatment of symptomatic paroxysmal atrial fibrillation. Europace. 2021;23:1931–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David B. De Lurgio.

Ethics declarations

Ethics approval

NA.

Consent to participate

NA.

Conflict of interest

The author declares no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This comment refers to the article available at https://doi.org/10.1007/s10840-022-01249-2

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

De Lurgio, D.B. Phased RF ablation with PVAC gold: evolution favors only the strong. J Interv Card Electrophysiol 65, 349–350 (2022). https://doi.org/10.1007/s10840-022-01323-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-022-01323-9

Navigation